GGAAF — NeuroMind AI Balance Sheet
0.000.00%
Last trade - 00:00- $1.23bn
- $1.23bn
- 26
- 69
- 11
- 27
Annual balance sheet for NeuroMind AI, fiscal year end - December 31st, millions except per share.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | |
| Standards: | — | USG | USG | USG |
| Status: | fx Preliminary | Final | Final | Final |
| Cash | ||||
| Cash and Short Term Investments | — | 2.33 | 1.2 | — |
| Prepaid Expenses | ||||
| Total Current Assets | — | 2.37 | 1.41 | — |
| Long Term Investments | ||||
| Total Assets | — | 259 | 264 | 1.05 |
| Accounts Payable | ||||
| Payable / Accrued | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | — | 0.642 | 19.4 | 5.34 |
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | — | 14.6 | 19.4 | 5.34 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Total Equity | — | 245 | 245 | -4.29 |
| Total Liabilities & Shareholders' Equity | — | 259 | 264 | 1.05 |
| Total Common Shares Outstanding |